You are here

Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of T2DM (VERIFY)

Wednesday, 18 September 2019,  13:15 - 14:15, Joslin Hall

Chair: C. Mathieu, BE

C. Mathieu, BE: Introduction and background

M. Stumvoll, DE: Rationale, design, methods

D.R. Matthews, UK: Main results and safety

S. Del Prato, IT: Summary and clinical implications

C.J. Bailey, UK: Commentary